Treatment of idiopathic membranous nephropathy in adults: KDIGO 2012, cyclophosphamide and cyclosporine A are out, rituximab is the new normal

The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guidelines for glomerulonephritis shed light on the complex world of glomerulonephritis therapy. However, they may no longer apply to idiopathic membranous nephropathy, as recently concluded by the KDIGO 2019 Working Group....

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas-Rivera, Jorge Enrique, Carriazo, Sol, Ortiz, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Glomerulonephritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768298/
https://www.ncbi.nlm.nih.gov/pubmed/31583088
http://dx.doi.org/10.1093/ckj/sfz127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768298/
https://www.ncbi.nlm.nih.gov/pubmed/31583088
http://dx.doi.org/10.1093/ckj/sfz127

Ejemplares similares